slit aperture with a large-aperture pattern of significant complexity. This converts the instrument into a computational sensor-the direct measurements must be computationally processed to derive a spectral estimate. The specific pattern we use was chosen to have mathematical properties that optimized the performance of this processing step. In essence, the pattern is designed so that each column of the pattern acts as a "virtual slit"-measuring the spectrum at high resolution and combining its results with all the other columns to dramatically increase the number of collected photons.
In June, we reported on the application of an instrument of this type to the problem of quantitative chemical detection in a highly scattering medium. 3 Using measurements made on liquid tissue phantoms spiked with varying concentrations of ethanol, we constructed a data model using a standard partial leastsquares algorithm. On a subsequent day, we used that model to accurately estimate (a) Predicted ethanol concentration vs. actual concentration. The samples being tested were prepared and measured on a subsequent day from when the data model was created. Perfect estimation would fall along the solid, diagonal line. The vertical, dashed line indicates a blood alcohol concentration of 0.08 percent by volume-the legal limit in many U.S. states. (b) Relative error of the estimation vs. actual concentration. The vertical, dashed line indicates a blood alcohol concentration of 0.08 percent by volume-the legal limit in many U.S. states. Setting an error threshold of 20 percent relative error indicates a detection limit of approximately 0.05 percent.
C linical application of Raman spectroscopy has been a longsought goal by virtue of its high chemical specificity and potential for quick, non-invasive measurement. Researchers envision a day when doctors can use Raman spectroscopy for in vivo monitoring of blood or tissue constituents-dramatically reducing the pain of blood samples and biopsies, as well as the minimizing the hazards from biosamples. However, despite great promise, significant clinical applications of Raman spectroscopy have yet to materialize. The cause: Weak signals caused by light scattering in tissue.
Raman spectroscopy is, fundamentally, a very inefficient process. In clinical applications, the low efficiency cannot be overcome with increased excitation power without the risk of damaging tissue. The challenge is compounded further by the fact that tissue is a highly-scattering environment that produces an extremely spatially-incoherent source. The ultimate task, then, is to measure the spectrum of a weak, incoherent source.
Traditional dispersive spectrometers, with their slit apertures, are a poor match to this problem. The constant-radiance theorem tells us that we can not concentrate the light from an incoherent source 1 , so the slit rejects the vast majority of the already small number of signal photons. Widening the slit is also not a solution, as that sacrifices spectral resolution and compromises the ability to distinguish Raman spectra of different molecules. A new approach to large-aperture spectrometry is the obvious solution.
In May of this year, we reported on our work in creating an inexpensive, mechanically robust, large-aperture spectrometer to solve just this problem. 2 In our design, we replaced the traditional the ethanol concentration in a new set of samples.
Setting an allowable relative error of 20 percent, our detection threshold was equivalent to a blood-alcohol concentration of 0.05 percent (see figure) . This is below the legal limit for intoxication, and well within commonly seen physiological ranges. Our successful quantitative measurements in a scattering medium, coupled with the fact that we succeeded while using excitation powers that pose no risk to patients, represents a significant step on the path toward the eventual clinical application of Raman spectroscopy. t 
